{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:50:18Z","timestamp":1765295418565,"version":"3.41.2"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Complete resection of the tumor and the ipsilateral thyroid lobe at the primary surgery is the \u201cgold standard\u201d for the treatment of parathyroid carcinoma (PC). However, differences in the overall survival (OS) of patients with PC who underwent partial and total surgical resection remain to be determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data on patients with PC who underwent partial and total surgical resection were extracted from the Surveillance, Epidemiology and End Results (SEER) database (2000\u20132018). The X-tile software (<jats:ext-link>https:\/\/medicine.yale.edu\/lab\/rimm\/research\/software\/<\/jats:ext-link>) was used to define the optimal cut-off values for continuous variables. The inverse probability of treatment weighting (IPTW) method was used to reduce the selection bias. IPTW-adjusted Kaplan\u2013Meier curves and Cox proportional hazards models were used to compare the OS of patients with PC in the partial and total surgical resection groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 334 patients with PC were included in this study (183 and 151 in the partial and total surgical resection groups, respectively). The optimal cut-off values for age at diagnosis were 53 and 73 years, respectively,  while that for tumor size was 34 mm. In both the Kaplan\u2013Meier analysis and univariable Cox proportional hazards regression analysis before IPTW, the difference in OS between the partial and total surgical resection groups was not statistically significant (p&amp;gt;0.05). These findings were confirmed in the IPTW-adjusted Kaplan\u2013Meier analysis and multivariate Cox proportional hazards regression analysis (p&amp;gt;0.05). Subgroup analysis revealed that total surgical resection was beneficial for OS only in the subgroup with unknown tumor size.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There was no significant difference in the prognosis of patients who underwent partial and total surgical resection. This finding may provide a useful reference for the treatment of PC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1167508","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T05:39:32Z","timestamp":1697434772000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of prognosis after partial and total surgical resection for parathyroid carcinoma: an inverse probability of treatment weighting analysis of the SEER database"],"prefix":"10.3389","volume":"14","author":[{"given":"Shuai","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaide","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6559-6","article-title":"Tumor size and presence of metastatic disease at diagnosis are associated with disease-specific survival in parathyroid carcinoma","volume":"25","author":"Lo","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/0284186X.2017.1306103","article-title":"A nationwide study on parathyroid carcinoma","volume":"56","author":"Ryh\u00e4nen","year":"2017","journal-title":"Acta Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2014.08.069","article-title":"Parathyroid carcinoma in more than 1,000 patients: A population-level analysis","volume":"156","author":"Sadler","year":"2014","journal-title":"Surgery"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.834362","article-title":"Genetics and epigenetics of parathyroid carcinoma","volume":"13","author":"Marini","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1761030","article-title":"Clinical features, treatment, and surveillance of hyperparathyroidism-jaw tumor syndrome: an up-to-date and review of the literature","volume":"2019","author":"Torresan","year":"2019","journal-title":"Int J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111676","article-title":"Parathyroid cancer: A review","volume":"11","author":"MaChado","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/CORR.0000000000000846","article-title":"Regional lymph node involvement is associated with poorer survivorship in patients with chondrosarcoma: A SEER analysis","volume":"477","author":"Wan","year":"2019","journal-title":"Clin Orthop Relat Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-010-0722-y","article-title":"Lymph node involvement and surgical approach in parathyroid cancer","volume":"34","author":"Schulte","year":"2010","journal-title":"World J Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2010.10.013","article-title":"Parathyroid cancer","volume":"37","author":"Sharretts","year":"2010","journal-title":"Semin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.2.7207","article-title":"Clinical review 122: Parathyroid carcinoma","volume":"86","author":"Shane","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.882579","article-title":"Non-linear correlation between tumor size and survival outcomes for parathyroid carcinoma: A SEER population-based cohort study","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3530-z","article-title":"Oncologic resection achieving r0 margins improves disease-free survival in parathyroid cancer","volume":"21","author":"Schulte","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11864-011-0171-3","article-title":"Parathyroid carcinoma: update and guidelines for management","volume":"13","author":"Wei","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s40618-016-0447-3","article-title":"Update on parathyroid carcinoma","volume":"39","author":"Cetani","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1003-6","article-title":"Clinical presentation, staging and long-term evolution of parathyroid cancer","volume":"17","author":"Talat","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2014.05.014","article-title":"Prognostic factors and staging systems in parathyroid cancer: a multicenter cohort study","volume":"156","author":"Villar-del-Moral","year":"2014","journal-title":"Surgery"},{"key":"B17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/cen.13055","article-title":"Preoperative diagnosis and prognosis in 40 Parathyroid Carcinoma Patients","volume":"85","author":"Xue","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2017.01.060","article-title":"Prognostic scoring system to risk stratify parathyroid carcinoma","author":"Silva-Figueroa","year":"2017","journal-title":"J Am Coll Surg"},{"volume-title":"SEER*Stat database: incidence - SEER research plus data, 18 registries, nov 2020 sub (2000-2018) - Linked To County Attributes - Total U.S., 1969-2019 Counties","year":"","key":"B19"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1673","article-title":"Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score","volume":"17","author":"Austin","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3238\/arztebl.2016.0597","article-title":"Propensity score: an alternative method of analyzing treatment effects","volume":"113","author":"Kuss","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.784599","article-title":"Prognostic analysis for patients with parathyroid carcinoma: A population-based study","volume":"16","author":"Qian","year":"2022","journal-title":"Front Neurosci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061426","article-title":"Parathyroid carcinoma: incidence, survival analysis, and management: A study from the SEER database and insights into future therapeutic perspectives","volume":"14","author":"Ullah","year":"2022","journal-title":"Cancers"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.850457","article-title":"A nomogram predicting the overall survival and cancer-specific survival in patients with parathyroid cancer: A retrospective study","volume":"13","author":"Tao","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08825-8","article-title":"The use and benefit of adjuvant radiotherapy in parathyroid carcinoma: A national cancer database analysis","volume":"28","author":"Limberg","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2022.10.012","article-title":"Predictive a nomogram for overall survival in patients with parathyroid cancer: A novel web-based calculator","author":"Yin","year":"2022","journal-title":"Asian J Surg"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1571","article-title":"Parathyroid carcinoma: a 43-year outcome and survival analysis","volume":"96","author":"Harari","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8898926","article-title":"Surgical disparities of parathyroid carcinoma: long-term outcomes and deep excavation based on a large database","volume":"2021","author":"Zhou","year":"2021","journal-title":"J Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/hed.20049","article-title":"Parathyroid carcinoma: a 22-year experience","volume":"26","author":"Busaidy","year":"2004","journal-title":"Head Neck"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102012","article-title":"Parathyroid cancer: An update","volume":"86","author":"Rodrigo","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2014.08.005","article-title":"Is central lymph node dissection necessary for parathyroid carcinoma","volume":"156","author":"Hsu","year":"2014","journal-title":"Surgery"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4672-3","article-title":"Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the national cancer data base (NCDB)","volume":"22","author":"Asare","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-021-01343-3","article-title":"Parathyroid carcinoma: a review","volume":"13","author":"Sawhney","year":"2022","journal-title":"Indian J Surg Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22599","article-title":"Trends in the incidence and treatment of parathyroid cancer in the United States","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14684","article-title":"Parathyroid carcinoma: Single centre experience","volume":"97","author":"Cunha","year":"2022","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1167508\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T05:39:37Z","timestamp":1697434777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1167508\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":35,"alternative-id":["10.3389\/fendo.2023.1167508"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1167508","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"article-number":"1167508"}}